Sosei Group makes its commercialization decisions separately for each product in its pipeline. These decisions will be based upon a number of factors including: Sosei’s financial strength, its development capabilities in a given therapeutic area, the market potential of the product and Sosei’s sales and marketing capability at a given time. The outcome of those decisions will determine whether to develop the product to a certain clinical stage and then out-license to a partner, or to develop it through to registration and then market the product in-house. This may differ from territory to territory.
